• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过德国全国新冠病毒血清学调查(NAT-COV-SURV)对抗体的血清阳性率研究,516 名德国重症监护和急诊医生中 SARS-CoV-2 阳性的流行率。

Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).

机构信息

Dept. of Anesthesiology, University Hospital Duesseldorf, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.

Dept. of Emergency Medicine, University Witten/Herdecke, Arnsberg, Germany.

出版信息

PLoS One. 2021 Apr 8;16(4):e0248813. doi: 10.1371/journal.pone.0248813. eCollection 2021.

DOI:10.1371/journal.pone.0248813
PMID:33831032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8031427/
Abstract

Healthcare personnel are at risk to aquire the corona virus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We evaluated the prevalence of SARS-CoV-2 antibodies and positive nasopharyngeal reverse transcriptase polymerase-chain reaction (RT-PCR) tests in German intensive care and emergency physicians. Physicians attending intensive care and emergency medicine training courses between June 16th and July 2nd 2020 answered a questionnaire and were screened for SARS-CoV-2 antibodies via automated electrochemiluminiscence immunoassay. We recruited 516 physicans from all parts of Germany, 445/516 (86%) worked in high risk areas, and 379/516 (73%) had treated patients with COVID-19. The overall positive rate was 18/516 (3.5%), 16/18 (89%) had antibodies against SARS-COV-2, another 2 reported previous positive RT-PCR results although antibody testing was negative. Of those positive, 7/18 (39%) were unaware of their infection. A stay abroad was stated by 173/498 (35%), mostly in Europe. 87/516 (17%) reported a febrile respiratory infection after January 1st 2020 which was related to SARS-CoV-2 in 4/87 (4.6%). Contact to COVID-19 positive relatives at home was stated by 22/502 (4.4%). This was the only significant risk factor for Covid-19 infection (Fisher´s exact test, p = 0.0005). N95 masks and eye protection devices were available for 87% and 73%, respectively. A total of 254/502 (51%) had been vaccinated against seasonal influenza. The overall SARS-CoV-2 infection rate of german physicians from intensive care and emergency medicine was low compared to reports from other countries and settings. This finding may be explained by the fact that the German health care system was not overwhelmed by the first wave of the SARS-CoV-2 pandemic.

摘要

医护人员面临感染 2019 年冠状病毒病(COVID-19)的风险,该病毒由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起。我们评估了德国重症监护和急诊医师中 SARS-CoV-2 抗体和鼻咽逆转录酶聚合酶链反应(RT-PCR)检测呈阳性的流行率。2020 年 6 月 16 日至 7 月 2 日期间参加重症监护和急诊医学培训课程的医师回答了一份问卷,并通过自动化电化学发光免疫分析筛查 SARS-CoV-2 抗体。我们从德国各地招募了 516 名医师,其中 445/516(86%)在高风险地区工作,379/516(73%)治疗过 COVID-19 患者。总阳性率为 18/516(3.5%),16/18(89%)对 SARS-COV-2 有抗体,另外 2 人报告了以前 RT-PCR 检测呈阳性的结果,尽管抗体检测呈阴性。在阳性者中,7/18(39%)不知道自己感染了。498 名中有 173 名(35%)报告称在 2020 年 1 月 1 日之后有发热性呼吸道感染,其中 87/516(17%)报告称在 2020 年 1 月 1 日之后有发热性呼吸道感染,其中 4/87(4.6%)与 SARS-CoV-2 有关。22/502(4.4%)报告称与家中 COVID-19 阳性亲属有接触。这是 COVID-19 感染的唯一显著危险因素(Fisher 精确检验,p = 0.0005)。N95 口罩和眼部防护设备的使用率分别为 87%和 73%。共有 254/502(51%)接种了季节性流感疫苗。与其他国家和地区的报告相比,德国重症监护和急诊医师的 SARS-CoV-2 总感染率较低。这一发现可能是由于德国医疗保健系统没有被 SARS-CoV-2 大流行的第一波压垮。

相似文献

1
Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).通过德国全国新冠病毒血清学调查(NAT-COV-SURV)对抗体的血清阳性率研究,516 名德国重症监护和急诊医生中 SARS-CoV-2 阳性的流行率。
PLoS One. 2021 Apr 8;16(4):e0248813. doi: 10.1371/journal.pone.0248813. eCollection 2021.
2
The seroprevalence of SARS-CoV-2 in a rural southwest community.农村西南社区 SARS-CoV-2 的血清阳性率。
J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.
3
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.
4
Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.2020 年 6 月日本 SARS-CoV-2 特异性抗体流行情况。
Emerg Infect Dis. 2021 Feb;27(2):628-631. doi: 10.3201/eid2702.204088.
5
Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders.一组市政急救人员中新冠病毒免疫球蛋白G抗体的流行情况
Prehosp Disaster Med. 2021 Apr;36(2):131-134. doi: 10.1017/S1049023X2000151X. Epub 2021 Jan 5.
6
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.德国西南部儿童及其父母中 SARS-CoV-2 感染的流行情况。
JAMA Pediatr. 2021 Jun 1;175(6):586-593. doi: 10.1001/jamapediatrics.2021.0001.
7
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.不同程度接触 2019 年冠状病毒病(COVID-19)患者的医护人员中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)抗体的血清阳性率。
Infect Control Hosp Epidemiol. 2020 Dec;41(12):1441-1442. doi: 10.1017/ice.2020.390. Epub 2020 Aug 3.
8
Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.德国一家二级保健医院卫生保健工作者中 SARS-CoV-2 的前瞻性血清流行病学评估。
Int J Infect Dis. 2021 Jan;102:136-143. doi: 10.1016/j.ijid.2020.10.026. Epub 2020 Oct 16.
9
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.加拿大第一波 COVID-19 疫情后献血者中的 SARS-CoV-2 血清流行率。
Transfusion. 2021 Mar;61(3):862-872. doi: 10.1111/trf.16296. Epub 2021 Feb 23.
10
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.在分娩期间对孕妇进行严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的全面筛查。
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:400-404. doi: 10.1016/j.ejogrb.2020.11.069. Epub 2020 Dec 1.

引用本文的文献

1
Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT.比较酶联免疫吸附试验(EIA)和蚀斑减少中和试验(PRNT)检测麻疹 IgG 评估麻疹血清学状态:麻疹 IgG EIA 和 PRNT 头对头分析的系统评价。
BMC Infect Dis. 2023 May 31;23(1):367. doi: 10.1186/s12879-023-08199-8.
2
Efficacy of personal protective equipment to prevent environmental infection of COVID-19 among healthcare workers: a systematic review.个人防护设备预防医护人员环境感染 COVID-19 的效果:系统评价。
Environ Health Prev Med. 2023;28:1. doi: 10.1265/ehpm.22-00131.
3
Influenza and Pneumococcal Vaccination and the Risk of COVID-19: A Systematic Review and Meta-Analysis.流感和肺炎球菌疫苗接种与新冠病毒病风险:一项系统评价和荟萃分析
Diagnostics (Basel). 2022 Dec 7;12(12):3086. doi: 10.3390/diagnostics12123086.
4
Compliance to Infection Prevention and Control Practices Among Healthcare Workers During COVID-19 Pandemic in Malaysia.马来西亚 COVID-19 大流行期间医护人员对感染预防和控制措施的遵从情况。
Front Public Health. 2022 Jul 18;10:878396. doi: 10.3389/fpubh.2022.878396. eCollection 2022.
5
Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year.德国一家二级保健医院网络的三家医院及其附属消防队员工中 SARS-CoV-2 抗体的血清阳性率:一项为期 1 年的重复横断面监测研究结果。
Int J Environ Res Public Health. 2022 Feb 19;19(4):2402. doi: 10.3390/ijerph19042402.
6
Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany.德国一家三级保健医院医护人员中 SARS-CoV-2 血清流行病学的纵向研究。
BMC Infect Dis. 2022 Jan 24;22(1):80. doi: 10.1186/s12879-022-07057-3.

本文引用的文献

1
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study.在一项前瞻性观察研究中观察到的 SARS-CoV-2 对医护人员的不同职业风险。
Elife. 2020 Aug 21;9:e60675. doi: 10.7554/eLife.60675.
2
COVID-19 in health care workers - A systematic review and meta-analysis.医护人员中的 COVID-19:系统评价和荟萃分析。
Am J Emerg Med. 2020 Sep;38(9):1727-1731. doi: 10.1016/j.ajem.2020.05.113. Epub 2020 Jun 6.
3
The time to do serosurveys for COVID-19 is now.现在是开展新冠病毒血清学调查的时候了。
Lancet Respir Med. 2020 Sep;8(9):836-838. doi: 10.1016/S2213-2600(20)30313-1. Epub 2020 Jul 24.
4
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
5
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.西班牙一家大型教学医院医护人员中 SARS-CoV-2 抗体的血清阳性率。
Nat Commun. 2020 Jul 8;11(1):3500. doi: 10.1038/s41467-020-17318-x.
6
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.田纳西州纳什维尔市医护人员照顾 COVID-19 患者首月期间 SARS-CoV-2 的血清流行率。
Clin Infect Dis. 2021 May 4;72(9):1645-1648. doi: 10.1093/cid/ciaa936.
7
Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff.临床医护人员中血清 IgG 抗体对 SARS-CoV-2 的流行情况。
PLoS One. 2020 Jun 25;15(6):e0235417. doi: 10.1371/journal.pone.0235417. eCollection 2020.
8
The history and value of face masks.口罩的历史与价值。
Eur J Med Res. 2020 Jun 23;25(1):23. doi: 10.1186/s40001-020-00423-4.
9
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
10
Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.医护人员中感知到的与实际存在的 SARS-CoV-2 特异性免疫应答。
Infection. 2020 Aug;48(4):631-634. doi: 10.1007/s15010-020-01461-0. Epub 2020 Jun 10.